Article Versions Notes

Previti S, Ettari R, Di Chio C, Ravichandran R, Bogacz M, Hellmich UA, Schirmeister T, Cosconati S, Zappalà M. Development of Reduced Peptide Bond Pseudopeptide Michael Acceptors for the Treatment of Human African Trypanosomiasis. Molecules. 2022; 27(12):3765. https://doi.org/10.3390/molecules27123765

Previti, Santo, Roberta Ettari, Carla Di Chio, Rahul Ravichandran, Marta Bogacz, Ute A. Hellmich, Tanja Schirmeister, Sandro Cosconati, and Maria Zappalà. 2022. "Development of Reduced Peptide Bond Pseudopeptide Michael Acceptors for the Treatment of Human African Trypanosomiasis" Molecules 27, no. 12: 3765. https://doi.org/10.3390/molecules27123765

Previti, S., Ettari, R., Di Chio, C., Ravichandran, R., Bogacz, M., Hellmich, U. A., Schirmeister, T., Cosconati, S., & Zappalà, M. (2022). Development of Reduced Peptide Bond Pseudopeptide Michael Acceptors for the Treatment of Human African Trypanosomiasis. Molecules, 27(12), 3765. https://doi.org/10.3390/molecules27123765